SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

SVB Leerink Maintains Outperform on Revolution Medicines, Lowers Price Target to $46

SVB Leerink analyst Jonathan Chang maintains Revolution Medicines (NASDAQ:RVMD) with a Outperform and lowers the price target from $55 to $46.

05/11/2021 06:25
SVB Leerink analyst Jonathan Chang maintains Revolution Medicines (NASDAQ:RVMD) with a Outperform and lowers the price target from $55 to $46.